Join us as Susan G. Komen^® continues our 3-Day webinar series with our next webinar focused on triple negative breast cancer. You will hear from our Komen Scholar, Dr. Jennifer Pietenpol, as she unwinds the complexity of triple negative breast cancer, and showcases how Komen funds have aided our understanding of triple negative breast cancer and helped pioneer novel treatment options and therapies.

This webinar will be hosted by:

• Carrie Stovall, Director, Events
• Michelle Martin-Pozo Ph.D., Director, Research Programs for Komen
• Jennifer Pietenpol, Ph.D., Executive Vice President for Research at Vanderbilt University Medical Center, Director of the Vanderbilt-Ingram Cancer Center, the B.F. Byrd Jr. Professor of Molecular Oncology, and Professor of Biochemistry, Cancer Biology and Otolaryngology at Vanderbilt University School of Medicine

The webinar will be 30 minutes long and you will have the opportunity to ask questions. Invite your friends, family and donors to participate and learn more about Komen’s research.

Jennifer Pietenpol, Ph.D., began her research focused on the signaling of one of the most commonly mutated genes in all of cancer: p53. More recently, Dr. Pietenpol has combined her research expertise in molecular genetics with bioinformatics to identify differences of triple negative breast cancer. Her studies have helped lead to several clinical trials aimed to help oncologists determine the most appropriate and precise treatment for breast cancer patients. Dr. Pietenpol has been recognized many times for her leadership and her work, and continues to help lead and shape cancer research nationally as demonstrated by her recent appointment to a panel advising Vice President Joe Biden’s National Cancer Moonshot.

Wednesday, September 14
11:00 a.m. - 11:30 a.m. CT

Click here to register for the webinar.